Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer

Published:2024-08-01 Issue:22 Volume:42 Page:2632-2636
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ríos-Hoyo Alejandro¹^ORCID,Cobain Erin²,Huppert Laura A.³,Beitsch Peter D.⁴,Buchholz Thomas A.⁵,Esserman Laura³,van 't Veer Laura J.³,Rugo Hope S.³,Pusztai Lajos¹^ORCID

Affiliation:

1. Yale Cancer Center, Yale School of Medicine, New Haven, CT

2. University of Michigan, Ann Arbor, MI

3. University of California San Francisco Comprehensive Cancer Center, San Francisco, CA

4. Dallas Surgical Group, Dallas, TX

5. Scripps Health, Scripps Clinic Medical Group, San Diego, CA

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.02614

Reference46 articles.

1. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

3. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer

4. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update

5. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP